Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-28

Clinical Trial Update: Pivmecillinam With Amoxicillin/Clavulanic Acid for Step Down Oral Therapy in ESBL UTIs [Phase 3]

View source ↗

Summary

Phase 3 trial investigating pivmecillinam with amoxicillin/clavulanic acid for step-down oral therapy in ESBL urinary tract infections, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amoxicillin/clavulanic acid (amoxicillin/clavulanic acid)
  • Pivmecillinam (pivmecillinam)

Snippet

Sponsor: Lund University | Conditions: Urinary Tract Infections, Bacteremia | Phase 3 | Status: RECRUITING